The FDA is cracking down on 14 companies which the agency claims is selling untested and unapproved cancer treatments online.
The USDA has quietly scrapped plans to start testing food for glyphosate, the primary component of the Monsanto-made herbicide RoundUp.
President Trump’s pick for head of the FDA, Dr. Scott Gottlieb, has deep ties to the pharmaceutical industry, receiving big bucks from drug makers.
A jury has awarded 6 people a whopping $1 billion over injuries they claim they received after being implanted with a faulty hip replacement device.
The government has approved the 1st major clinical trial of Ecstasy to treat people with PTSD that has not responded to traditional therapy.
Under the 21st Century Cures Act, the FDA would be able to approve new drugs even faster than they are approved now. However, expediting drug approvals has proven deadly in the past.
After communities in the Florida Keys disagreed over trials of GMO mosquitoes in the area, the mosquito control board has voted to go forward with the test.
A panel is recommended that the FDA approve a new experimental antibiotic, but deep concerns remain over the drug’s potential to cause serious liver injury.
The USDA has approved 2 new GMO potatoes. If the FDA and EPA give them the all-clear in January, they could reach the market by spring.
On October 12, the DEA announced it would not ban kratom, an herb used as a natural medicine. Public comment on the ban will be open until December 1.
Antitobacco groups have filed a lawsuit against the FDA, which had vowed to put graphic warnings on cigarette packs by June 2011.
The world’s first “artificial pancreas” has been approved by the FDA for people with Type 1 diabetes. Will life now be easier for diabetics?
The FDA is seeking public comment on what the definition of “healthy” should be as it applies to foods. Current standards may surprise you.
Just weeks after finding traces of glyphosate in U.S. honey, the FDA says it has found the herbicide in oatmeal and oat products.
A marijuana-based childhood epilepsy drug has taken 1 step closer to approval after phase 3 clinical trial results kids had a 42% reduction in seizures.
The FDA will host a contest that will allow programmers to submit a smartphone app designed to reduce opioid overdose deaths.
A leading group of pediatricians warned this week that codeine should never be used in children for pain relief or as a cough suppressant.